In Boston, infant nutrition company NAMUH and cell programming giant Ginkgo Bioworks have announced a multi-product collaboration to develop Human Milk Oligosaccharides (HMOs) structurally identical to those found in human breast milk. HMOs are essential, fiber-like nutrients unique to human milk that provide an important energy source to beneficial gut bacteria in infants. Despite being […]
In Massachusetts, Ginkgo Bioworks and the biotechnology company Zymergen (have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization. Under the terms of the agreement, which have been unanimously approved by the boards of directors of both companies, Zymergen […]
In Boston, synthetic biology firm Ginkgo Bioworks and Sumitomo Chemical have announced a partnership to identify biobased ingredients for cosmetics and personal care applications. Sumitomo Chemical will leverage Ginkgo’s codebase and expertise in organism engineering to sustainably produce molecules used in products across a broad range of industries. The target molecule is planned to be […]
Using astronaut blood to build infrastructure on Mars sounds like part of a sci-fi movie but researchers are working on doing just that thanks to a protein in human blood and an acid in human urine that can bind to Mars dust to create a material strong enough to build infrastructure. In today’s Digest, there’s […]
In New York, Ginkgo Bioworks began trading on the New York Stock Exchange on Friday, September 17 under the ticker DNA. Debuting at around $15 billion, the SPAC deal raised an estimated $1.6 billion for the Boston-based synthetic biology company. The company reported $88 million in sales in the first half of 2021, tracking […]
In Massachusetts, Ginkgo Bioworks, Inc. announced a new cell program in partnership with Huue, a biotech startup that’s pioneering sustainable bio-based dyes for the fashion industry and beyond. Ginkgo, which recently announced a business combination with Soaring Eagle Acquisition Corp., serves customers across industries seeking to develop new and better products using biology. Huue will […]
In Boston, newly public synthetic biology firm Ginkgo Bioworks will undertake strain engineering services for Bolt Threads. Under the terms of the agreement, Gingko will use its platform to improve the “sustainability, efficiency and cost-effectiveness” of Bolt Threads’ b-silk protein manufacturing process. b-silk is currently available in premium product lines like Vegamour hair care products—which […]
Who’s in Hot Water? Some of the Usual Suspects get into the usual trouble. We note that EPA missed the 2021 Renewable Volume Obligation deadline, and Growth Energy threatens a lawsuit. Really. We get tired of reporting on the industry having to (almost annually) sue the government to compel compliance to the law. It’s a […]
Synthetic biology. It sounds like something from a sci-fi movie, or an oxymoron like jumbo shrimp or clearly confused. After all, biology is the study of living organisms. And synthetic means made by chemical synthesis, especially to imitate a natural product. But synthetic biology has real potential to replace costly or unsustainable manufacturing processes and […]
Bioengineering…it doesn’t sound very magical but it is full of mystery and potential waiting to be unlocked, much like Harry Potter’s character. In the early books and movies, Harry is young, mysterious, smart, and you just know he is capable of something great and destined for amazing things. We feel the same about bioengineering and […]
